Close

G1 Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference Apr 4, 2024 10:30AM
G1 Therapeutics Provides First Quarter 2023 Financial Results and Operational Highlights May 3, 2023 06:30AM
G1 Therapeutics to Participate in the 22nd Annual Needham Virtual Healthcare Conference Apr 11, 2023 12:30PM
G1 Therapeutics Provides Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights Mar 1, 2023 06:30AM
G1 Therapeutics Provides Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights Mar 1, 2023 06:30AM
View Older Stories

Nov 22, 2022 04:01PM G1 Therapeutics Announces Closing of Offering of Common Stock
Nov 22, 2022 04:01PM G1 Therapeutics Announces Closing of Offering of Common Stock
Nov 18, 2022 05:13AM G1 Therapeutics (GTHX) Prices 7.7M Share Offering at $6.50/sh
Nov 17, 2022 08:12PM G1 Therapeutics Announces Pricing of Offering of Common Stock
Nov 17, 2022 08:12PM G1 Therapeutics Announces Pricing of Offering of Common Stock
May 4, 2022 03:51PM G1 Therapeutics (GTHX) PT Lowered to $42 at Needham & Company
Apr 14, 2022 06:04AM Needham & Company Reiterates Buy Rating, $44 Price Target on G1 Therapeutics (GTHX)
Apr 6, 2022 11:30AM G1 Therapeutics to Participate in the 21st Annual Needham Virtual Healthcare Conference
Apr 7, 2021 07:00AM G1 Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference
Apr 7, 2020 07:00AM G1 Therapeutics to Present at 19th Annual Needham Virtual Healthcare Conference on April 14, 2020
Apr 2, 2019 07:00AM G1 Therapeutics to Present at the 18th Annual Needham Healthcare Conference
Apr 2, 2019 07:00AM G1 Therapeutics to Present at the 18th Annual Needham Healthcare Conference
Dec 20, 2018 09:29AM Pre-Open Stock Movers 12/20: (AGEN) (TLRY) (PTE) Higher; (DBVT) (ADMA) (SPPI) Lower (more...)
Nov 8, 2018 08:23AM G1 Therapeutics (GTHX) PT Lowered to $74 at Needham & Company
Sep 21, 2018 04:05PM G1 Therapeutics Announces Closing of Offering of Common Stock
Sep 21, 2018 04:05PM G1 Therapeutics Announces Closing of Offering of Common Stock
Sep 19, 2018 05:49AM G1 Therapeutics (GTHX) Prices 3M Share Common Offering at $60/Sh
Sep 18, 2018 09:37PM G1 Therapeutics Announces Pricing of Offering of Common Stock
Sep 18, 2018 09:37PM G1 Therapeutics Announces Pricing of Offering of Common Stock
Sep 17, 2018 10:33AM G1 Therapeutics (GTHX) PT Raised to $76 at Needham & Company as Protocol Amendment
Jun 25, 2018 07:59AM Needham & Company Reiterates Buy on G1 Therapeutics
May 17, 2018 10:31AM G1 Therapeutics (GTHX) PT Raised to $60 at Needham & Company; 'Early G1T38 Data Consistent with Best-in-Class Profile'
Mar 13, 2018 05:56AM G1 Therapeutics (GTHX) PT Raised to $42 at Needham & Company
Mar 12, 2018 04:05PM G1 Therapeutics Announces Closing of Offering of Common Stock
Mar 12, 2018 04:05PM G1 Therapeutics Announces Closing of Offering of Common Stock
Mar 8, 2018 05:16AM G1 Therapeutics (GTHX) Prices 3.4M Shares at $29.50
Mar 7, 2018 09:54PM G1 Therapeutics Announces Pricing of Offering of Common Stock
Mar 7, 2018 09:54PM G1 Therapeutics Announces Pricing of Offering of Common Stock
Mar 6, 2018 09:28AM Pre-Open Movers 03/06: (AMDA) (CLBS) (GNCA) Higher; (GLYC) (FRPT) (ASNA) Lower (more...)
Mar 1, 2018 07:00AM G1 Therapeutics to Present at Investor Conferences in March 2018
Mar 1, 2018 07:00AM G1 Therapeutics to Present at Investor Conferences in March 2018
Jun 12, 2017 07:10AM Needham & Company Starts G1 Therapeutics (GTHX) at Buy; Unique and Best-in-Class Oncology Drug Development
Jun 12, 2017 12:49AM Needham & Company Starts G1 Therapeutics (GTHX) at Buy
May 23, 2017 08:00AM G1 Therapeutics Announces Closing of Initial Public Offering
May 17, 2017 10:52AM G1 Therapeutics (GTHX) IPO Opens Flat
May 17, 2017 05:52AM G1 Therapeutics (GTHX) IPO Prices at $15
May 16, 2017 07:25PM G1 Therapeutics Announces Pricing of Initial Public Offering
May 8, 2017 09:02AM G1 Therapeutics Announces Launch of Initial Public Offering
View Older Stories